| HOME >> MEDICINE >> TECHNOLOGY |
GREENWICH, Conn., May 19 /PRNewswire/ -- Helix Health, the first U.S.
stand-alone genomic medicine practice, is hosting a 90-minute webcast this
Wednesday, May 21, 2008 from 1:00-2:30 PM EDT examining:
How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer
To register, point your browser here http://event.netbriefings.com/event/helixhealth/register.html .
Every hour, 150 people in the United States are diagnosed with cancer.
There is a growing number of people who are not willing to wait for that
diagnosis. They are undergoing genetic testing to discover, and to know
what they must do to manage these risks... personalized medicine for
effective heath care management.
Topics:
What should a doctor and patient do when a patient tests positive?
What is the risk in taking a "wait and see" approach?
Are there alternatives to radical surgery?
What are potential tort issues in predictive genetic testing and medical
uses of genetic tests?
Panel:
Steven A.R. Murphy, MD - Clinical Genetics Fellow at Yale School of
Medicine, and Helix Health's Managing Partner will moderate the panel.
Barbara A. Ward, MD - Director, The Breast Center of Greenwich Hospital;
principal investigator of the STAR Trial
http://www.ynhh.org/healthlink/cancer/cancer_7_99.html; surgical
oncologist affiliated with Yale-New Haven Health System.
Jessica Queller - author of Pretty Is What Changes; television writer for
Felicity, The Gilmore Girls and One Tree Hill. Writer/producer on Gossip
Girl.
Jennifer Ibrahim, MD - clinical geneticist specializing in preconception
genetics as well as familial cancer syndromes.
David Ewing Duncan - bestsel
'/>"/>
| SOURCE Helix Health Copyright©2008 PR Newswire. All rights reserved |